These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 20946183

  • 1. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR, Scofield TL, Moulds JJ, Swanson JL.
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [Abstract] [Full Text] [Related]

  • 2. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE.
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [Abstract] [Full Text] [Related]

  • 3. Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-beta and prostaglandin E2.
    Branch DR, Shabani F, Lund N, Denomme GA.
    Transfusion; 2006 Aug; 46(8):1316-22. PubMed ID: 16934066
    [Abstract] [Full Text] [Related]

  • 4. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M, Mataija M, Sović D, Dodig J, Matijević R, Kukuruzović M.
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [Abstract] [Full Text] [Related]

  • 5. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM.
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract] [Full Text] [Related]

  • 6. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L, Alie-Daram S, Roubinet F, Valat AS, Depoortère MH, Fournié A, Puech F.
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract] [Full Text] [Related]

  • 7. A curious case of anti-D antibody titer.
    Hensley JG, Coughlin KP, Klein LL.
    J Midwifery Womens Health; 2009 Sep; 54(6):497-502. PubMed ID: 19879523
    [Abstract] [Full Text] [Related]

  • 8. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R, Shokri F.
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [Abstract] [Full Text] [Related]

  • 9. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S, Hisano M, Suzuki T, Sago H, Murashima A, Yamaguchi K.
    J Clin Apher; 2011 Dec; 26(4):216-8. PubMed ID: 21506141
    [Abstract] [Full Text] [Related]

  • 10. The safety of RhIG in the prevention of haemolytic disease of the newborn.
    Hirose TG, Mays DA.
    J Obstet Gynaecol; 2007 Aug; 27(6):545-57. PubMed ID: 17896248
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D, Lazarus AH.
    Hematology Am Soc Hematol Educ Program; 2009 Aug; ():185-91. PubMed ID: 20008198
    [Abstract] [Full Text] [Related]

  • 12. Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
    Freda VJ, Gorman JG, Pollack W, Bowe E.
    N Engl J Med; 1975 May 08; 292(19):1014-6. PubMed ID: 804134
    [Abstract] [Full Text] [Related]

  • 13. The continuing struggle to eliminate hemolytic disease of the newborn from RH (D).
    Barlow JF.
    S D J Med; 1999 Jan 08; 52(1):7-8. PubMed ID: 9926725
    [No Abstract] [Full Text] [Related]

  • 14. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.
    Hartwell EA.
    Am J Clin Pathol; 1998 Sep 08; 110(3):281-92. PubMed ID: 9728602
    [Abstract] [Full Text] [Related]

  • 15. Prevention of Rh sensitization in the context of trauma: two case reports.
    Werch JB.
    J Clin Apher; 2010 Sep 08; 25(2):70-3. PubMed ID: 20027640
    [Abstract] [Full Text] [Related]

  • 16. [Immune cytopenias in newborns].
    Brossard Y.
    Rev Prat; 2001 Sep 15; 51(14):1571-6. PubMed ID: 11757274
    [Abstract] [Full Text] [Related]

  • 17. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K, Vŭlcheva B.
    Akush Ginekol (Sofiia); 1986 Sep 15; 25(3):84-90. PubMed ID: 3019168
    [No Abstract] [Full Text] [Related]

  • 18. The use of Rh immune globulin: a review.
    Sutton GP, Jay A, Lim YS, Noland JE, Boral LI.
    Indiana Med; 1988 Apr 15; 81(4):321-2. PubMed ID: 2834434
    [No Abstract] [Full Text] [Related]

  • 19. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B, Spasova K.
    Akush Ginekol (Sofiia); 1985 Apr 15; 24(2):73-6. PubMed ID: 2990248
    [No Abstract] [Full Text] [Related]

  • 20. [Adverse effects and patient information].
    Cortey A, Brossard Y.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb 15; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.